MaxCyte Inc at Bank of America Healthcare Conference Transcript
(technical difficulty)
And thank you for attending the MaxCyte presentation today. Been a long day, but I appreciate your interest, and hopefully make this an interesting discussion for you all.
So MaxCyte is listed on both NASDAQ and the London Stock Exchange. I won't read this. I'm sure you've see them dozens of times. So our focus is on the engineering of cells. So we have a technology that we have developed over the years, and it's based on a technology called Flow Electroporation we invented. And we have over 500 platforms in the field. And this platform allows our partners to engineer virtually any cell at any scale with any engineering molecule.
The technology was developed by MaxCyte. This company is a product story. We do not have a service. So everything we'll talk about today is based on our own technology, our own manufactured products and the revenues we receive from selling those products and licensing the technology.
So we lead the industry in important
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
